Quantcast
Home manage Las Vegas Review-Journal
  Jobs Cars Homes Shopping Travel Weddings Golf Best of Las Vegas Photo   Search:

RECENT EDITIONS
Mon Tue Wed Thu Fri Sat Sun

sponsored by
Business


IN BRIEF

Progressive Gaming announces deals

Technology provider Progressive Gaming International Corp. announced on Monday a pair of partnerships with slot machine giant International Game Technology, including an expansion of the companies' server-based gaming agreement.


Most Popular Stories
  • Fraud with Portent
  • Expect to pay at Nugget's new tower
  • Debt-ridden casino operators told to expect pressure
  • REAL ESTATE: Las Vegas home prices stabilize as threat of foreclosure flood wanes
  • GAMING COMPANY EARNINGS: Station drops $455.4 million
  • REAL ESTATE: Short sales on the rise
  • THE STRIP: License approved for Aria
  • GLOBAL GAMING EXPO: Recession over? Don't bet on it
  • Foreclosure wave continues
  • Union wants insiders to help pull Station from bankruptcy




  • Las Vegas-based Progressive Gaming said it entered into a $15 million convertible note transaction with IGT and a new credit facility and term loan agreement with a private equity group for $18 million. Progressive plans to use the proceeds to retire the remaining $30 million of the company's debt.

    In addition, Progressive said it will expand its strategic technology alliance with IGT and will transfer its Casinolink Jackpot Station technology to the Reno-based slot maker, but will retain license to continue to market the standard jackpot features of the technology.

    NEW YORK

    ImClone says offer undervalues company

    ImClone Systems' board of directors said Monday cancer drug partner Bristol-Myers Squibb Co.'s $4.5 billion buyout offer "substantially undervalues" the company, with Chairman Carl Icahn against the deal.

    Despite calling the bid too low, ImClone stopped short of rejecting it and said its board formed a committee to weigh the offer. The board also said it is considering splitting the company into two units to focus on Erbitux and its developing pipeline separately.

    The New York-based companies are partners on the colon- and head-and-neck-cancer treatment Erbitux. They are also currently developing the drug as a lung cancer therapy.

    "As we stated last week, we believe we've made a fair offer and we look forward to a response from ImClone's board on that offer," Bristol-Myers spokeswoman Tracy Furey said.

    NEW YORK

    Oil prices tumble to three-month low

    Oil prices plunged to a three-month low Monday, dropping $3.69 to close at $121.41 after briefly tumbling below $120 a barrel. The sell-off came after Tropical Storm Edouard seemed less likely to disrupt oil and natural gas output in the Gulf of Mexico.

    Crude's steep drop dragged down other commodities from corn to copper and mimicked the big nosedives of the past three weeks, adding to growing beliefs that the oil bubble is at least temporarily deflating.

    "What this means is that we're going to see some more relief at the pump. We're probably looking at another 10 cents of downside in retail gas prices," said Tom Kloza, publisher and chief analyst at Oil Price Information Service in Wall, N.J. A gallon of regular gasoline fell on average about half a penny overnight to $3.881.

    NEW YORK

    Treasury prices show decrease

    Treasury bond prices weakened Monday as investors prepared for this week's issuance of $27 billion worth of new government debt and the Federal Reserve's meeting on interest rates..

    The 10-year Treasury note fell 0.22 points to 99.25 points. Its yield rose to 3.97 percent from 3.94 percent late Friday, according to BGCantor Market Data. Yields move in the opposite direction of prices.

    The 30-year long bond fell 0.41 points to 96.5 points. Its yield rose to 4.59 percent from 4.56 percent Thursday.

    Newsvine Digg Fark Technorati reddit StumbleUpon del.icio.us Slashdot Propeller Mixx Furl Twitter MySpace Facebook Google Bookmarks Yahoo! Bookmarks Windows Live Favorites Ask MyStuff myAOL Favorites

    Leave Your Comment 0 Reader Comments
    Terms & Conditions
    The following comments are provided by readers and are the sole responsiblity of the authors. The reviewjournal.com does not review comments before publication nor guarantee their accuracy. By publishing a comment here you agree to abide by the comment policy. If you see a comment that violates the policy, please notify the web editor.

    Some comments may not display immediately due to an automatic filter. These comments will be reviewed within 48 hours. Please do not submit a comment more than once.
    Current Word Count:

    Note: Comments made by reporters and editors of the Las Vegas Review-Journal are presented with a yellow background.